I represent public and private emerging companies, including leading life sciences companies, on general corporate and transactional matters. I assist clients with corporate, governance, securities, licensing and contractual matters, as well as capital markets and M&A transactional matters. I often work with emerging companies from inception through IPO and beyond. I also work with a number of leading venture capital firms on their investment transactions.